Anzatax
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
OBJECTIVE
Low water solubility, high systemic toxicity and insignificant cellular uptake have limited efficient clinical…
Aerosolized chemotherapeutics leads to higher, localized and continuous concentrations of active agents in lung tissue with lower…
A simple, rapid, and sensitive reversed-phase HPLC method was developed and validated for determination of paclitaxel (PTX) in…
Abstract A water-insoluble anti-tumor agent, paclitaxel (PTX) was successfully incorporated into novel-targeted polymeric…
Objective:To observe the efficacy,tolerance and adverse effect of anzatax and cisplatin combined chemotherapy in the treatment of…
BACKGROUND
Paclitaxel is an active agent in the treatment of breast, ovarian, lung and head and neck cancers. In previous phase I…
BACKGROUND
Despite its moderate anti-tumour activity in head and neck cancers there have been no reports on the activity of…
To determine the efficacy and safety of paclitaxel given as a three‐hour infusion in patients with metastatic breast cancer which…